FDA Drug Approval, N019049, RETIN-A

FDA Drug Approval, N019049, RETIN-A

Regular price $49.00 USD
Regular price Sale price $49.00 USD
Sale Sold out
NDA: 019049
Company: BAUSCH
Drug Name: RETIN-A
Active Ingredients: TRETINOIN
Strength: CREAM;TOPICAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: STANDARD
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details